Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q15726: Variant p.Asn115Lys

Metastasis-suppressor KiSS-1
Gene: KISS1
Feedback?
Variant information Variant position: help 115 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Asparagine (N) to Lysine (K) at position 115 (N115K, p.Asn115Lys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and polar (N) to large size and basic (K) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In HH13; significantly reduced efficacy as well as potency. Any additional useful information about the variant.


Sequence information Variant position: help 115 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 138 The length of the canonical sequence.
Location on the sequence: help PAPQGAVLVQREKDLPNYNW N SFGLRFGKREAAPGNHGRSA The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         PAPQGAVLVQREKDLPNYNWNSFGLRFGKREAAPGNHGRSA

Mouse                         PAPRGAVLVQREKDLSTYNWNSFGLRYGRRQAA------RA

Rat                           PAPRGSVLVQREKDMSAYNWNSFGLRYGRRQVA------RA
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 20 – 138 Metastasis-suppressor KiSS-1
Peptide 68 – 121 Metastin
Peptide 108 – 121 Kisspeptin-14
Peptide 109 – 121 Kisspeptin-13
Peptide 112 – 121 Kisspeptin-10
Region 112 – 121 Essential for receptor binding and receptor activation
Region 115 – 138 Disordered
Modified residue 112 – 112 Phosphotyrosine
Modified residue 121 – 121 Phenylalanine amide



Literature citations
Inactivating KISS1 mutation and hypogonadotropic hypogonadism.
Topaloglu A.K.; Tello J.A.; Kotan L.D.; Ozbek M.N.; Yilmaz M.B.; Erdogan S.; Gurbuz F.; Temiz F.; Millar R.P.; Yuksel B.;
N. Engl. J. Med. 366:629-635(2012)
Cited for: VARIANT HH13 LYS-115; CHARACTERIZATION OF VARIANT HH13 LYS-115;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.